person

Ewa G. B.

Country
Poland
Department
Centrum Wsparcia Badań Klinicznych

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 5 partner sites.

Specializations

Hematologic Malignancies

Focused on therapeutic strategies for blood‑borne cancers and related disorders.

  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Chronic Lymphocytic Leukemia
  • Myeloid Leukemia in Children with Down Syndrome
  • Relapsed or Refractory Multiple Myeloma
  • Classical Hodgkin Lymphoma
  • Central Nervous System Lymphoma
  • Hepatoblastoma and Hepatocellular Carcinoma
  • Colorectal Cancer
  • Ovarian Epithelial Cancer

Research conducted at the Pomeranian Medical University.

Autoimmune and Inflammatory Disorders

Investigations target immune‑mediated diseases and systemic inflammation.

  • Systemic Lupus Erythematosus
  • Idiopathic Inflammatory Myopathy
  • Myasthenia Gravis
  • Giant Cell Arteritis
  • Graves’ Disease
  • SAPHO Syndrome
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Secondary Progressive Multiple Sclerosis
  • Chronic Graft‑versus‑Host Disease
  • Interstitial Lung Disease secondary to Systemic Sclerosis

Therapeutic focus includes biologics, immunomodulators and targeted agents.

Metabolic and Endocrine Disorders

Efforts concentrate on rare metabolic diseases and hormonal deficiencies.

  • Phenylketonuria
  • Prader‑Willi Syndrome
  • Growth Hormone Deficiency
  • Congenital Adrenal Hyperplasia
  • Type 1 Diabetes Mellitus
  • Presymptomatic Diabetes Type 1 (Stage 1)
  • Metabolic Disorders – Phenylketonuria
  • Hyperthyroidism
  • Hypothyroidism
  • Graves’ Disease

Studies evaluate enzyme replacement, gene‑targeted therapies and hormone replacement.

Cardiovascular and Thrombotic Conditions

Research addresses heart failure phenotypes, ischemic stroke prevention and anticoagulation reversal.

  • Heart Failure with Preserved Ejection Fraction
  • Heart Failure with Reduced Ejection Fraction
  • Myocardial Injury after Non‑cardiac Surgery
  • Prevention of Ischemic Stroke after Acute Non‑cardioembolic Stroke
  • Patients on Factor Xa Inhibitor needing urgent intervention
  • Reversal of Anticoagulation Effect in Patients on Direct Oral Factor Xa Inhibitors
  • Ivabradine for Myocardial Injury Prevention
  • CDR132L in Heart Failure with Left Ventricular Hypertrophy
  • Asundexian for Stroke Prevention
  • Antithrombotic Strategies in High‑Risk Patients

Therapeutic focus includes novel anticoagulants, reversal agents and cardioprotective drugs.

Respiratory and Pulmonary Diseases

Efforts target chronic lung conditions and related upper airway disorders.

  • Chronic Obstructive Pulmonary Disease
  • Chronic Rhinosinusitis with Nasal Polyps
  • Comorbid Asthma
  • Chemotherapy‑induced Nausea and Vomiting
  • Prevention of Oesophageal Strictures after Endoscopic Submucosal Dissection
  • General Anaesthesia Safety in Respiratory Patients
  • Bronchopulmonary Infections in Immunocompromised Hosts
  • Pulmonary Toxicity Management
  • Respiratory Support in Oncology Trials
  • Airway Management in Surgical Settings

Key therapeutic areas include inhaled agents, anti‑emetic regimens and peri‑operative respiratory care.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.